Post
Qiagen’s QIAstat-Dx respiratory diagnostic wins FDA clearance
The US Food and Drug Administration (FDA) has cleared Qiagen’s QIAstat-Dx Respiratory Panel Plus syndromic test, designed for pathogen detection …
Analog Devices’s Sensinel CPM system reduces heart fluid in published study
A study has been published highlighting that the Sensinel cardiopulmonary management (CPM) system by Analog Devices (ADI) effectively detects signs …
Siemens Healthineers announces £250m UK MRI facility
Medical device giant Siemens Healthineers has announced a $250m investment in a new UK production facility aimed at manufacturing superconducting …
Dementia Action Week 2024: the future of Alzheimer’s diagnostics
Dementia Action Week 2024, which starts today, shines a spotlight on Alzheimer’s disease, the most common cause of dementia. The approval …
Triomics wins $15m for oncology GenAI software
Triomics has raised $15m to further develop its oncology-specialised generative AI (GenAI) platform OncoLLM. OncoLLM is designed to help cancer centres …
FDA approval paves way for Masimo’s debut in OTC baby monitoring sector
The Covid-19 pandemic has significantly accelerated the pace of innovation in the healthcare IT market, as health systems worldwide have …
Industry takes: the importance of keeping healthcare businesses cybersecure
Cybersecurity is vital for all industries, but there are in which breaches have more impact than healthcare. Threats like patient data …
UK NICE backs Exact’s Oncotype cancer genomic test
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Exact Sciences’s genomic test Oncotype …
Freyja wins FDA clearance for VereSee device
Early-stage medical device company Freyja Healthcare has received 510(k) clearance from the US Food and Drug Administration (FDA) for its …
Neuralink’s first brain chip implant faces setback
Neuralink has reported an unexpected setback with its first chip implanted in a human skull, as the device began detaching …
R3 Vascular secures funding to support bioresorbable scaffold trial
Medical device company R3 Vascular has successfully closed an $87m Series B financing round led by affiliates of Deerfield Management, …
UK MHRA pilots AI Airlock regulatory sandbox
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched its artificial intelligence (AI) Airlock sandbox model designed to …
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
The global healthcare sector has witnessed both unprecedented challenges and achievements over the past few years, most notably during the …
OrthoXel’s Vertex Hip Fracture Nail system obtains US clearance
OrthoXel has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its Vertex Hip Fracture Nail (HFN), …
Field Medical begins ventricular PFA technology trial
Field Medical has announced the commencement of first-in-human trials for its FieldForce pulsed field ablation (PFA) system at Na Homolce …